24.03.2020 • NewsCoronavirusCOVID-19Wiley

Wiley Supports Research on Novel Coronavirus with Free-to-Access Content

Scientific publisher Wiley is making a collection of journal articles and our...
Scientific publisher Wiley is making a collection of journal articles and our book chapters on coronavirus research freely available to the global scientific community. © Atypon

Scientific publisher Wiley is making a collection of journal articles and our book chapters on coronavirus research freely available to the global scientific community. In response to the call to action from OSTP (White House Office of Science and Technology Policy) and other governments, Wiley will start feeding content into PubMed Central as it comes in and licensing it to maximize discoverability and usability. PubMed Central is a free full-text archive of biomedical and life sciences journal literature at the U.S. National Institutes of Health's National Library of Medicine.

„As a publisher of trusted health science, we’ve made the relevant research articles, book chapters and entries in our major references freely available below, in support of the global efforts in diagnosis, treatment, prevention and further research in this disease and similar viral respiratory infections”, says Charles Young, Editor in Chief, International Journal of Clinical Practice. He continues: “Our approach is to use the world-class information we have available to directly improve health and to support the virtual efforts of healthcare practitioners globally. We are continually monitoring the developments and we will update the content of this page periodically.“

On workdays, newly published articles are made free within 24 hours of publication. Articles published after 14:00 (EST) on Friday will be made free the following Monday. The articles freely available at Wiley can be found here on the Wiley Online Library.

Company

CHEManager c/o Wiley-VCH Verlag GmbH & Co. KGaA

Boschstr. 12
69469 Weinheim

Company contact







Free Virtual Event

ProteiNext 2025

ProteiNext 2025

ProteiNext is an annual symposium that offers a platform for sharing insights on protein analysis

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.